{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:44:07Z","timestamp":1773661447792,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,2,14]],"date-time":"2003-02-14T00:00:00Z","timestamp":1045180800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> We report the identification of a new mutation in exon 28 of the von Willebrand factor (<jats:italic>VWF<\/jats:italic>) gene in two related patients with type 2M von Willebrand disease (VWD). The molecular abnormality changes the Ser 1285 to Phe within the A1 loop of VWF. The S1285F mutation was reproduced by site\u2010directed mutagenesis on the full\u2010length VWF cDNA. The mutated recombinant VWF (rVWF), F1285rVWF, and the hybrid, S\/F1285rVWF, were expressed in COS\u20107 cells. F1285rVWF exhibited a slight decrease of high\u2010molecular\u2010weight multimers and markedly reduced ristocetin\u2010 or botrocetin\u2010induced binding of VWF to platelets in association with a decreased binding to botrocetin. The hybrid S\/F1285rVWF showed a normal multimeric profile and bound to platelets in a similar way to the patients' plasma VWF, in the presence of ristocetin or botrocetin. Thus, the new S1285F mutation within the A1 loop was responsible for the type 2M VWD observed in these patients, and was involved in the binding of VWF to botrocetin and to platelet glycoprotein Ib (GPIb). Three anti\u2010VWF monoclonal antibodies, with conformational epitopes within the A1 loop but distinct GPIb binding inhibitory properties, showed a different interaction with F1285\u2010rVWF. These results indicate that the S1285F substitution alters the folding of the A1 loop and prevents the correct exposure of the VWF binding sites to botrocetin and GPIb.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04168.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:51:13Z","timestamp":1047365473000},"page":"643-651","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease"],"prefix":"10.1111","volume":"120","author":[{"given":"Alain","family":"Stepanian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne\u2010Sophie","family":"Ribba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Maurice","family":"Lavergne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Fressinaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Juhan\u2010Vague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Mazurier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Pierre","family":"Girma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,2,14]]},"reference":[{"key":"e_1_2_18_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3796.012k05_3796_3803"},{"key":"e_1_2_18_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00447a009"},{"key":"e_1_2_18_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00160a027"},{"key":"e_1_2_18_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0398-189"},{"key":"e_1_2_18_6_1","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood.V83.12.3553.3553","article-title":"Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand Factor","volume":"83","author":"Christophe O.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_18_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03400.x"},{"key":"e_1_2_18_8_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.17.10396"},{"key":"e_1_2_18_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(78)91322-0"},{"key":"e_1_2_18_10_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0038-1647310","article-title":"Ristocetin and botrocetin involve two distinct domains of von Willebrand Factor for binding to platelet membrane glycoprotein Ib","volume":"64","author":"Girma J.P.","year":"1990","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_18_11_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1345"},{"key":"e_1_2_18_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.3.1010.1010"},{"key":"e_1_2_18_13_1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0037-1613995","article-title":"Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor","volume":"84","author":"Hilbert L.","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_18_14_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613060"},{"key":"e_1_2_18_15_1","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V91.5.1572","article-title":"Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin, but not botrocetin\u2010mediated binding of von Willebrand factor to platelets","volume":"91","author":"Hillery C.A.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_18_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb02862.x"},{"key":"e_1_2_18_17_1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1182\/blood.V70.5.1577.1577","article-title":"Localization of a collagen\u2010interactive domain of human von Willebrand Factor between amino acid residues Gly 911 and Glu 1365","volume":"70","author":"Kalafatis M.","year":"1987","journal-title":"Blood"},{"key":"e_1_2_18_18_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2820129"},{"key":"e_1_2_18_19_1","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type\u2010IIA von Willebrand disease mutations","volume":"267","author":"Lyons S.E.","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_18_20_1","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.V88.7.2559.bloodjournal8872559","article-title":"Type 2M: Milwaukee\u20101 von Willebrand disease: an in\u2010frame deletion in the Cys509\u2013Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets","volume":"88","author":"Mancuso D.J.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_18_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.22.13406"},{"key":"e_1_2_18_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.15.11044"},{"key":"e_1_2_18_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb02937.x"},{"key":"e_1_2_18_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0137"},{"key":"e_1_2_18_25_1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to Factor VIII","volume":"5","author":"Nishino M.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_18_26_1","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.V93.6.1959.406k01_1959_1968","article-title":"Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib","volume":"93","author":"Obert B.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_18_27_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614779"},{"key":"e_1_2_18_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.20.9846"},{"key":"e_1_2_18_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.4.952"},{"key":"e_1_2_18_30_1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler J.E.","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_18_31_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.67.1.395"},{"key":"e_1_2_18_32_1","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1016\/S0021-9258(18)92954-6","article-title":"Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor\u2010dependent agglutination of platelets","volume":"266","author":"Scott J.P.","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_18_33_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/s-0038-1650599","article-title":"Characterization of recombinant von Willebrand factors mutated on cysteine 509 or 695","volume":"76","author":"Siguret V.","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_18_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V70.5.1679.1679"},{"key":"e_1_2_18_35_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.17.12763"},{"key":"e_1_2_18_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s005990050046"},{"key":"e_1_2_18_37_1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0037-1614642","article-title":"New assay for measuring binding of platelet glycoprotein IIb\/IIIa to unpurified von Willebrand factor","volume":"82","author":"Veyradier A.","year":"1999","journal-title":"Thrombosis and Haemostasis"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04168.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04168.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:34:29Z","timestamp":1697456069000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04168.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04168.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04168.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]},"assertion":[{"value":"2003-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}